Gral Medical

What Gral Medical does

Gral Medical (legal entity SC GRAL MEDICAL SRL) is a Romanian private healthcare services provider headquartered in Bucharest, operating a vertically integrated network spanning diagnostic clinics, in-house molecular biology and anatomical pathology laboratories, imaging centers, and specialty hospitals across more than 40 cities in Romania. The company's core offering is diagnostic and treatment services across multiple specialties, with a strategic emphasis on oncology delivered through the OncoFort sub-brand (chemotherapy, radiotherapy, surgery, dialysis, multidisciplinary tumor boards), supplemented by the Tiroida 360° thyroid care program, the Centrul de Excelenta in Patologia Sanului (breast pathology center of excellence), and ancillary lines including dialysis (Dialifort), lithotripsy (Fortlit), occupational medicine, and wellness (Gral Recharge Wellness). Proprietary technology components include a molecular biology lab offering BRCA testing, NGS panels, and Real-Time PCR; an in-house pathology laboratory with immunohistochemistry turnaround in five working days; and a CNAS-contracted genetic testing panel covering ovarian, breast, colorectal, and lung cancers. Patient-facing digital channels include a native iOS/Android app for appointment booking and results access, online scheduling via gralmedical.ro, call-center booking (*4725, 021-323-00.00), telemedicine for oncology first/second opinions, and home self-collection diagnostic kits (Autorecoltare) for HPV, colorectal cancer screening, and sexually transmitted infections, distributed via courier.

Revenue is generated through multiple streams: per-service patient fees (consultations priced at 300–360 Lei), CNAS national health insurance reimbursements for genetic oncology testing, radioiodine therapy, and contracted analyses, annual family/individual medical subscription packages (Abonamente), the Cardul de Sanatate FAVOR accumulation health card, occupational health contracts with corporate clients, and home testing kit sales. Disclosed scale metrics include a H1 2021 revenue of 25 million EUR (suggesting ~50M EUR annualized), a 7 million EUR 2021 capex budget for two oncology hospitals and new regional labs, a 251–500 employee headcount, a 90-bed main hospital spanning 5,000 sqm in Bucharest, and a 76% patient satisfaction score in 2022 (up from 72% in 2021).

Name

Gral Medical

Legal name

SC GRAL MEDICAL SRL

Website

https://gralmedical.ro

Company type

Private

Operating status

Operating

Headcount range

251–500 employees

Short description

Gral Medical is a Romanian private healthcare network operating diagnostic clinics, in-house molecular biology and pathology laboratories, imaging centers, and OncoFort oncology hospitals across more than 40 cities, serving individual patients with oncology, genetic testing, thyroid care, dialysis, and home self-collection diagnostics.

Ownership category

akta.pro rank

Product category

Private Healthcare Services

NAICS

Medical and Diagnostic Laboratories (62151), Medical and Diagnostic Laboratories (6215), Offices of Physicians (62111), Diagnostic Imaging Centers (621512), Freestanding Ambulatory Surgical and Emergency Centers (621493), Ambulatory Health Care Services (621)

SIC

Services-Medical Laboratories (8071), Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Specialty Outpatient Facilities, Nec (8093), Services-General Medical & Surgical Hospitals, Nec (8062)

akta.pro primary industry

Central Laboratory Services (Core Lab Operations) (HLAGAEAA)

akta.pro secondary industries

Oncology Telemedicine Platforms (HLALAGAH), Cross-Border Telemedicine, Second Opinion & Care Navigation Facilitators (THAKAIAM), Oncology & Specialty Treatment Travel Agencies (THAKAIAI)

Keywords

• Diagnostic laboratory services
• Oncology treatment services
• Medical imaging services
• Anatomical pathology testing
• Occupational health services

Headquarters

HQ city

Bucharest

HQ country

Romania

HQ region

Europe

Offices16 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Supply Chain, Marketing or Sales, Technology or R&D

Revenue model

1. Patient Service Fees: Direct payments from patients for consultations, laboratory tests, imaging services, and procedures. Fees are quoted per service with consultation prices ranging from 300-360 Lei depending on physician seniority.
2. CNAS Health Insurance Reimbursement: Services reimbursed through Romania's National Health Insurance (Casa Națională de Asigurări de Sănătate) including genetic testing for cancer patients, certain oncology treatments, and contracted medical services.
3. Corporate Medical Packages: Annual medical subscription packages (Abonamente) for individuals and families offering preventive care, discounted services, and accumulated savings on medical expenses.
4. Occupational Medicine Services: Workplace health services including pre-employment examinations, periodic check-ups, and workplace safety assessments for corporate clients.
5. Home Testing Kit Sales: Sale of home testing kits for HPV, colorectal cancer screening, and STI testing delivered via courier with results sent electronically.

Pricing tiers

Go-to-market motion2 records

Distribution channels7 records

Marketing channels7 records

Core offering

Gral Medical operates an integrated private healthcare network in Romania delivering diagnostic laboratory tests, medical imaging, outpatient specialty consultations, anatomical pathology, molecular biology and genetic testing, and oncology care through its OncoFort center. Services are delivered through more than 40 owned clinics, laboratories, imaging centers and oncology units, supported by an online booking platform, mobile app and telemedicine channel for patient access. The portfolio also includes home sample collection, occupational health for corporate clients, and preventive subscription-style medical packages for individuals and families.

Product overview

Gral Medical is a Romanian private healthcare network offering a comprehensive portfolio of medical services across multiple locations. The core offering consists of laboratory analyses (Analize de Laborator), medical imaging (CT, MRI, Mammography, X-ray), pathological anatomy services, and medical consultations. The company operates specialized sub-brands including OncoFort for comprehensive oncology services (chemotherapy, radiotherapy, surgery), and provides specialized programs like Tiroida 360° for thyroid care and a Breast Pathology Center of Excellence. Self-collection diagnostic kits (Autorecoltare) for HPV, colorectal cancer screening, and sexually transmitted infections enable remote testing. Additional services include dialysis (DialiFort), occupational medicine, medical subscriptions (Abonamente), and a proprietary mobile application for appointment booking and results access.

Differentiator

Problem solved

Functional benefit

Brands

• OncoFort: Oncology hospital brand offering surgery, chemotherapy, radiotherapy, and cancer treatment services
• Dialifort
• Fortlit
• Cardul de Sanatate FAVOR
• Gral Recharge Wellness

Products and services

• Diagnostic laboratory testing Centralized clinical laboratory tests (blood, urine, biochemistry, immunology, microbiology, etc.) processed at Gral's own labs and accessible via own collection centers, home-visit phlebotomy, online results delivery and CNAS reimbursement where contracted.
• Medical imaging services MRI, CT, ultrasound, mammography, X-ray and other imaging scans delivered at Gral's imaging centers, with radiologist reporting and integration with referring specialists in the same network.
• OncoFort oncology center Specialized oncology service combining oncology consultations, chemotherapy administration, onco-genetic / hereditary cancer screening and integrated diagnostics for cancer patients, delivered through the OncoFort center within the Gral network.
• Anatomical pathology and molecular biology services Histopathology, cytology and molecular biology testing performed in Gral's in-house labs to support cancer diagnosis, hereditary risk assessment and complex disease workups for both Gral clinicians and external referrers.
• Outpatient specialty consultations Consultations with specialist physicians (e.g., cardiology, internal medicine, endocrinology, gynecology, oncology) delivered in Gral clinics and via telemedicine/telecounseling, with the option of an integrated diagnostic workup in the same network.
• Occupational medicine (medicina muncii) Pre-employment, periodic and return-to-work medical examinations, drug testing and workplace health assessments for employer clients, delivered at Gral clinics or on-site under corporate contract.
• Home sample collection (visit la domiciliu) Phlebotomy and biological sample collection at a patient's home or workplace, with courier transport to Gral labs and subsequent online results delivery.
• Preventive medical subscription packages Pre-paid subscription packages that bundle an annual set of laboratory tests, imaging and/or specialist consultations, including the OncoFort hereditary cancer screening package, marketed to individual and family subscribers.

Quantifiable outcome

• Patient satisfaction rate of 76% in 2022, increased from 72% in 2021
• +6 more outcomes

Named customers2 records

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Partnerships

One partnership is on record.

• AKH Vienna (Austria)coreStrategic or Co-development Partner · 1 January 2010Since 2010, renowned oncologists from AKH Vienna have chosen OncoFort to provide monthly first and second opinion oncology consultations for neoplastic patients from Romania, facilitating access to international medical expertise without patients needing to travel abroad.

Scale indicators7 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Affidea: European diagnostic imaging and outpatient services operator with Romanian clinics. Comparable to Gral's imaging arm (CT, MRI, mammography, DXA) and outpatient diagnostic offering.
• Sanador: Romanian private hospital and clinic group with strong presence in Bucharest and major specialties including oncology and imaging. Comparable to Gral's mix of inpatient and outpatient services, though with greater concentration in the capital.
• Hiperdia: Romanian private imaging and diagnostic center network with national footprint. Comparable to Gral's radiology and imaging centers and to its broader outpatient diagnostics strategy.
• Medicover: Swedish-headquartered healthcare and diagnostics operator with significant operations across Romania and CEE. Comparable through its integrated clinics, hospitals, and diagnostic lab footprint and its subscription/corporate health model.
• MedLife: Romania's largest private healthcare operator with a national network of hospitals, clinics, and laboratories (including the Synevo diagnostic lab chain). Directly comparable to Gral Medical in multi-specialty clinic + lab + hospital offering across Romania, but at meaningfully larger scale.
• Regina Maria: One of the top private healthcare networks in Romania with hospitals, polyclinics, and laboratories nationwide. Closely comparable to Gral in operating a broad ambulatory and inpatient portfolio with corporate subscription packages and CNAS-contracted services.
• Synevo: Leading diagnostic laboratory chain in Romania and CEE, now part of MedLife. Directly comparable to Gral's laboratory services (Analize de Laborator, Anatomie Patologica, Biologie Moleculara) as the dominant reference-lab competitor.
• Bioclinica: Romanian medical laboratory network focused on routine and specialty diagnostics. Comparable to Gral's laboratory services portfolio, particularly for routine blood, biochemistry, and microbiology testing.

Broad incumbents

• AKH Vienna (Allgemeines Krankenhaus der Stadt Wien): Major university hospital in Vienna and Gral's strategic oncology partner since 2010. Comparable in clinical oncology depth rather than in business model; relevant because the partnership sets the international clinical benchmark for OncoFort.

Regional players

• Anima Speciality Medical Services: Romanian outpatient polyclinic chain focused on specialty consultations and diagnostics. Comparable as a competitor for outpatient consultation and lab volumes in the regions where both Gral and Anima operate.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/user/GralMedical
• Facebookfacebook.com/GralMedical.servicii.medicale
• LinkedInlinkedin.com/company/sc-gral-medical-srl
• Instagraminstagram.com/gral.medical
• TikToktiktok.com/@gral.medical
• Xx.com/gral_medical

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries13 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Gral Medical